Match!
Fergus Caskey
University of Bristol
Intensive care medicineKidney diseaseRenal replacement therapyDiabetes mellitusMedicine
273Publications
26H-index
2,102Citations
What is this?
Publications 272
Newest
#1Nicholas C. Chesnaye (PHRI: Public Health Research Institute)H-Index: 6
#2Friedo W. Dekker (LUMC: Leiden University Medical Center)H-Index: 83
Last. Christoph WannerH-Index: 80
view all 11 authors...
INTRODUCTION Understanding the mechanisms underlying the differences in renal decline between men and women may improve sex-specific clinical monitoring and management. To this end, we aimed to compare the slope of renal function decline in older men and women in chronic kidney disease (CKD) Stages 4 and 5, taking into account informative censoring related to the sex-specific risks of mortality and dialysis initiation. METHODS The European QUALity Study on treatment in advanced CKD (EQUAL) study...
Source
#1Barnaby Hole (UoB: University of Bristol)H-Index: 5
#2K. EvansH-Index: 1
Last. Kirsten L. JohansenH-Index: 54
view all 16 authors...
#1Samantha Hayward (UoB: University of Bristol)
#2Barnaby Hole (UoB: University of Bristol)H-Index: 5
Last. Christoph WannerH-Index: 80
view all 18 authors...
BACKGROUND People with chronic kidney disease (CKD) are at high risk of polypharmacy. However, no previous study has investigated international prescribing patterns in this group. This article aims to examine prescribing and polypharmacy patterns among older people with advanced CKD across the countries involved in the European Quality (EQUAL) study. METHODS The EQUAL study is an international prospective cohort study of patients ≥65 years of age with advanced CKD. Baseline demographic, clinical...
Source
#1Sabine N. van der Veer (University of Manchester)H-Index: 19
#2Angelo Ercia (University of Manchester)H-Index: 2
Last. Sarah Knowles (Ebor: University of York)H-Index: 1
view all 8 authors...
Routinely collecting and using electronic patient-reported outcome (ePRO) data in clinical practice can improve patients' experience and outcomes, but implementing this at scale has proved challenging. As part of the Optimising routine collection of electronic patient-reported outcomes (OPT-ePRO) study, we therefore developed an intervention that aimed to facilitate the implementation of ePROs. We are conducting OPT-ePRO in the context of secondary care for people with chronic kidney disease in ...
Source
#1M S Ali (UoB: University of Bristol)
#1M S Ali (UoB: University of Bristol)
Last. Cyrus Cooper (University of Oxford)H-Index: 178
view all 13 authors...
Bisphosphonates are contraindicated in moderate-to-severe chronic kidney disease patients. However, they are used to prevent fragility fractures in patients with impaired kidney function, despite a lack of evidence on their effects on bone density in these patients. We demonstrated that Alendronate had a positive effect on bone in these patients. PURPOSE This study aimed to assess the association between alendronate use and bone mineral density (BMD) change in subjects with moderate-severe chron...
Source
#1Katie Wong (UoB: University of Bristol)
#2Yoav Ben-Shlomo (UoB: University of Bristol)H-Index: 92
Last. Pippa Bailey (UoB: University of Bristol)H-Index: 2
view all 8 authors...
Source
#1Katie Wong (UoB: University of Bristol)
#2Fergus Caskey (UoB: University of Bristol)H-Index: 26
Last. Pippa Bailey (UoB: University of Bristol)H-Index: 2
view all 5 authors...
Source
#1Katie Wong (UoB: University of Bristol)
#2Fergus Caskey (UoB: University of Bristol)H-Index: 26
Last. Pippa Bailey (UoB: University of Bristol)H-Index: 2
view all 5 authors...
Source
#1Emma O’Lone (USYD: University of Sydney)H-Index: 12
#2Andrea K. Viecelli (UQ: University of Queensland)H-Index: 7
Last. Vera KraneH-Index: 32
view all 66 authors...
Cardiovascular disease (CVD) affects more than two-thirds of patients receiving hemodialysis and is the leading cause of death in this population, yet CVD outcomes are infrequently and inconsistently reported in trials in patients receiving hemodialysis. As part of the Standardised Outcomes in Nephrology-Haemodialysis (SONG-HD) initiative, we convened a consensus workshop to discuss the potential use of myocardial infarction and sudden cardiac death as core outcome measures for CVD for use in al...
Source
#1Dunia Alarkawi (Garvan Institute of Medical Research)H-Index: 3
#2M. Sanni Ali (University of Oxford)H-Index: 6
Last. Bo Abrahamsen (University of Oxford)H-Index: 47
view all 17 authors...
Oral bisphosphonates (oBPs) have been associated with reduced fractures and mortality. However, their risks and benefits are unclear in patients with moderate-severe CKD. This study examined the association between oBPs and all-cause mortality in G3B-5D CKD. This is a population-based cohort study including all subjects with an estimated glomerular filtration rate (eGFR) <45/mL/min/1.73 m(2) (G3B: eGFR <45/mL/min/1.73 m(2) G4: eGFR 15-29/mL/min/1.73 m(2) G5: eGFR <15/mL/min/1.73 m(2) G5D: hemodi...
Source
12345678910